TD Cowen analyst Gary Taylor lowered the firm’s price target on Acadia Healthcare to $86 from $90 and keeps an Outperform rating on the shares. The firm said the recurring strength of the company’s SS revenue growth makes them incrementally optimistic regarding 2024-25 EBITDA growth particularly as the company anniversaries recent corporate investments.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACHC: